$1.15
-0.25-17.86%
al cierre: Nov 20, 4:00 PM EST
$1.16
0.010.87%
After hour: 5:09 PM EST

Acrivon Therapeutics (ACRV) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 16, 2026 | $-0.42 | $-0.44 | 4.55 % |
| Q2 | Aug 12, 2026 | $-0.43 | $-0.50 | 14.0 % |
| Q1 | May 13, 2026 | $-0.49 | $-0.51 | 3.92 % |
| Q4 | Mar 19, 2026 | $-0.49 | $-0.47 | -4.26 % |
Quarterly Revenue (Billions)
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 16, 2026 | $0 | $606.00K | -100.0 % |
| Q2 | Aug 12, 2026 | $0 | $464.00K | -100.0 % |
| Q1 | May 13, 2026 | $0 | $498.30K | -100.0 % |
| Q4 | Mar 19, 2026 | $0 | $541.60K | -100.0 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.44 | $-0.50 | $-0.51 | $-0.47 |
| Actual | $-0.42 | $-0.43 | $-0.49 | $-0.49 |
| Surprise | +4.55% | +14.0% | +3.92% | -4.26% |
| Revenue | ||||
| Estimate | $606000 | $464000 | $498304 | $541598 |
| Actual | $0 | $0 | $0 | — |
| Surprise | -100.0% | -100.0% | -100.0% | -100.0% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.44 | $-0.37 | $-0.41 | $-0.44 |
| Revenue | ||||
| Consensus | — | — | — | — |